BioTricity Inc. Files 8-K on Security Holder Votes
Ticker: BTCY · Form: 8-K · Filed: Jul 12, 2024 · CIK: 1630113
Sentiment: neutral
Topics: corporate-governance, sec-filing
TL;DR
BioTricity Inc. filed an 8-K for security holder votes - details to follow.
AI Summary
BioTricity Inc. filed an 8-K on July 12, 2024, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about the votes or their outcomes, but it serves as a formal notification to the SEC regarding these corporate actions.
Why It Matters
This filing indicates that BioTricity Inc. has held or is holding votes that could impact corporate governance or strategic decisions, requiring disclosure to investors.
Risk Assessment
Risk Level: low — The filing is a procedural notification of votes and does not disclose any immediate financial or operational risks.
Key Players & Entities
- BIOTRICITY INC. (company) — Registrant
- July 12, 2024 (date) — Date of report
- Nevada (jurisdiction) — State of incorporation
- 001-40761 (identifier) — Commission File Number
- 203 Redwood Shores Parkway, Suite 600 Redwood City, California 94065 (address) — Principal Executive Offices
- (650) 832-1626 (phone_number) — Registrant's telephone number
FAQ
What specific matters were submitted to a vote of BioTricity Inc.'s security holders?
The filing does not specify the exact matters voted upon, only that such matters were submitted.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on July 12, 2024.
What is BioTricity Inc.'s state of incorporation?
BioTricity Inc. is incorporated in Nevada.
What is the principal executive office address for BioTricity Inc.?
The principal executive offices are located at 203 Redwood Shores Parkway, Suite 600, Redwood City, California 94065.
What is the Commission File Number for BioTricity Inc.?
The Commission File Number for BioTricity Inc. is 001-40761.
Filing Stats: 407 words · 2 min read · ~1 pages · Grade level 11.1 · Accepted 2024-07-12 16:12:36
Key Financial Figures
- $0.001 B — ch registered Common Stock, Par Value $0.001 BTCY Nasdaq Capital Market Indicate
Filing Documents
- form8-k.htm (8-K) — 33KB
- 0001493152-24-027090.txt ( ) — 201KB
- btcy-20240712.xsd (EX-101.SCH) — 3KB
- btcy-20240712_lab.xml (EX-101.LAB) — 33KB
- btcy-20240712_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: July 12, 2024 BIOTRICITY INC. By: /s/ Waqaas Al-Siddiq Waqaas Al-Siddiq Chief Executive Officer